Weight Loss Drugs Spark NHS Access Debate and Beer Sales Warning
MPs have criticized NHS plans to offer Mounjaro to only 6% of eligible patients by 2028 as unambitious, while Heineken warns that the popularity of GLP-1 drugs like Wegovy could reduce beer consumption in British pubs.
